Not logged in Share Save
Share Save
Progressive multifocal leukoencephalopathy and BIZ virus-nephropathy with bispecific antibody therapy in multiple myeloma Siegel, Ariel; Reci, Sidorela; Grossman, Leah; Gleason, Charles; Crary, John; Song, Lusheng; Park, Jin; Verina, Daniel; Desai, Shriya; Kappes, Katerina; Stillman, Isaac; LaBaer, Joshua; Aleman, Adolfo; Jagannath, Sundar; Parekh, Samir Share Save
Share Save
Share Save
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma Pan, Darren; Mouhieddine, Tarek H.; Sheng, Tianxiang; Fu, Weijia; Moshier, Erin; Richter, Joshua; Parekh, Samir; Jagannath, Sundar; Rossi, Adriana C.; Sanchez, Larysa J.; Thibaud, Santiago; Rodriguez, Cesar; Cho, Hearn J.; Richard, Shambavi Share Save
Share Save
Share Save
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry Ailawadhi, Sikander; Lee, Hans C.; Omel, James; Toomey, Kathleen; Hardin, James W.; Gasparetto, Cristina J.; Jagannath, Sundar; Rifkin, Robert M.; Durie, Brian G. M.; Narang, Mohit; Terebelo, Howard R.; Joshi, Prashant; Jou, Ying-Ming; Mouro, Jorge; Yu, Edward; Abonour, Rafat Share Save
Elotuzumab-Iberdomide-Dexamethasone Combination Therapy Activates T and NK Cells within the Immune Microenvironment of Multiple Myeloma Patients Chen, Lucia Y.; Amatangelo, Michael; Aleman, Adolfo; Van Oekelen, Oliver; Nevers, Tania; Sun, Yongliang; Pierceall, William E.; Kappes, Katerina; Blangiardo, Anna; Jagannath, Sundar; Rodriguez, Cesar; Parekh, Samir Share Save
A Phase 2 Study of Daratumumab in Combination with Dose-Attenuated Bortezomib, Lenalidomide, and Dexamethasone in Transplant Ineligible Older Adults with Newly Diagnosed Multiple Myeloma Sanchez, Larysa J.; Moshier, Erin; Lieberman-Cribbin, Alex; Richter, Joshua; Richard, Shambavi; Rossi, Adriana; Rodriguez, Cesar; Thibaud, Santiago; Cho, Hearn Jay; Parekh, Samir; Jagannath, Sundar; Chari, Ajai Share Save
Share Save
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes Thibaud, Santiago; Subaran, Ryan L.; Newman, Scott; Lagana, Alessandro; Melnekoff, David T.; Bodnar, Saoirse; Ram, Meghana; Soens, Zachry; Genthe, William; Brander, Tehilla; Mouhieddine, Tarek H.; Van Oekelen, Oliver; Houldsworth, Jane; Cho, Hearn Jay; Richard, Shambavi; Richter, Joshua; Rodriguez, Cesar; Rossi, Adriana; Sanchez, Larysa; Chari, Ajai; Moshier, Erin; Jagannath, Sundar; Parekh, Samir; Onel, Kenan Share Save
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4 Hansen, Doris K.; Lu, Xiaoxiao; Puglianini, Omar Castaneda; Sorensen, Sonja; Usmani, Saad Z.; Zhang, Eileen; Huo, Stephen; Zhang, Yan; Qureshi, Zaina P.; Jagannath, Sundar Share Save
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes Skerget, Sheri; Penaherrera, Daniel; Chari, Ajai; Jagannath, Sundar; Siegel, David S.; Vij, Ravi; Orloff, Gregory; Jakubowiak, Andrzej; Niesvizky, Ruben; Liles, Darla; Berdeja, Jesus; Levy, Moshe; Wolf, Jeffrey; Usmani, Saad Z.; Christofferson, Austin W.; Nasser, Sara; Aldrich, Jessica L.; Legendre, Christophe; Benard, Brooks; Miller, Chase; Turner, Bryce; Kurdoglu, Ahmet; Washington, Megan; Yellapantula, Venkata; Adkins, Jonathan R.; Cuyugan, Lori; Boateng, Martin; Helland, Adrienne; Kyman, Shari; McDonald, Jackie; Reiman, Rebecca; Stephenson, Kristi; Tassone, Erica; Blanski, Alex; Livermore, Brianne; Kirchhoff, Meghan; Rohrer, Daniel C.; D'Agostino, Mattia; Gamella, Manuela; Collison, Kimberly; Stumph, Jennifer; Kidd, Pam; Donnelly, Andrea; Zaugg, Barbara; Toone, Maureen; McBride, Kyle; DeRome, Mary; Rogers, Jennifer; Craig, David; Liang, Winnie S.; Gutierrez, Norma C.; Jewell, Scott D.; Carpten, John; Anderson, Kenneth C.; Cho, Hearn Jay; Auclair, Daniel; Lonial, Sagar; Keats, Jonathan J. Share Save
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma Saldarriaga, Mateo Mejia; Pan, Darren; Unkenholz, Caitlin; Mouhieddine, Tarek H.; Velez-Hernandez, Juan Esteban; Engles, Katherine; Fein, Joshua A.; Monge, Jorge; Rosenbaum, Cara; Pearse, Roger; Jayabalan, David; Gordillo, Christian; Chan, Hei Ton; Yamshon, Samuel; Thibaud, Santiago; Mapara, Markus; Inghirami, Giorgio; Lentzsch, Suzanne; Reshef, Ran; Rossi, Adriana; Parekh, Samir; Jagannath, Sundar; Richard, Shambavi; Niesvizky, Ruben; Bustoros, Mark Share Save
Share Save
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma Coffey, David G.; Osman, Keren; Aleman, Adolfo; Bekri, Selma; Kats, Simone; Dhadwal, Amishi; Catamero, Donna; Kim-Schulze, Seunghee; Gnjatic, Sacha; Chari, Ajai; Parekh, Samir; Jagannath, Sundar; Cho, Hearn Jay Share Save
Linvoseltamab, a B-cell maturation antigen-targeted T-cell-engaging bispecific antibody, induces deep and durable responses in patients with relapsed or refractory multiple myeloma including difficult-to-treat subgroups Jagannath, Sundar; Richter, Joshua; Dhodapkar, Madhav V.; Hoffman, James E.; Lee, Hans C.; Suvannasankha, Attaya; Shah, Mansi R.; Lentzsch, Suzanne; Zonder, Jeffrey A.; Baz, Rachid; Maly, Joseph J.; Namburi, Swathi; Wu, Ka Lung; Pianko, Matthew; Silbermann, Rebecca; Min, Chang-Ki; Vekemans, Marie-Christiane; Munder, Markus; Byun, Ja Min; Lopez, Joaquin Martinez; DeVeaux, Michelle; Chokshi, Dhruti; Boyapati, Anita; Hazra, Anasuya; Lorenc, Karen Rodriguez; Kroog, Glenn S.; Houvras, Yariv; Bumma, Naresh Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
